| 中文名 | (4-甲基哌嗪-1-基)(4-硝基苯基)甲酮 |
|---|---|
| 英文名 | (4-methylpiperazin-1-yl)-(4-nitrophenyl)methanone |
| 英文别名 |
Methanone, (4-methyl-1-piperazinyl)(4-nitrophenyl)-
(4-Methyl-1-piperazinyl)(4-nitrophenyl)methanone |
| 密度 | 1.3±0.1 g/cm3 |
|---|---|
| 沸点 | 423.9±40.0 °C at 760 mmHg |
| 分子式 | C12H15N3O3 |
| 分子量 | 249.266 |
| 闪点 | 210.1±27.3 °C |
| 精确质量 | 249.111343 |
| PSA | 69.37000 |
| LogP | 0.31 |
| 蒸汽压 | 0.0±1.0 mmHg at 25°C |
| 折射率 | 1.588 |
| 储存条件 | 室温,干燥 |
| 危害码 (欧洲) | Xi |
|---|---|
| 海关编码 | 2933599090 |
|
~84%
21091-98-5 |
| 文献:SUPERGEN, INC. Patent: US2008/214558 A1, 2008 ; Location in patent: Page/Page column 23-24 ; US 20080214558 A1 |
|
~92%
21091-98-5 |
| 文献:ENDO PHARMACEUTICALS INC.; SMITH, Roger, Astbury; THOMPSON, Scott, Kevin; HOSAHALLI, Subramanya; BEJUGAM, Mallesham; NANDURI, Srinivas; PANIGRAHI, Sunil, Kumar; MAHALINGAM, Natarajan Patent: WO2012/58671 A1, 2012 ; Location in patent: Page/Page column 79 ; |
|
~68%
21091-98-5 |
| 文献:ENDO PHARMACEUTICALS INC.; SMITH, Roger, Astbury; THOMPSON, Scott, Kevin; HOSAHALLI, Subramanya; BEJUGAM, Mallesham; NANDURI, Srinivas; PANIGRAHI, Sunil, Kumar; MAHALINGAM, Natarajan Patent: WO2012/58671 A1, 2012 ; Location in patent: Page/Page column 81 ; |
| 上游产品 5 | |
|---|---|
| 下游产品 3 | |
| 海关编码 | 2933599090 |
|---|---|
| 中文概述 | 2933599090. 其他结构上有嘧啶环的化合物(包括其他结构上有哌嗪环的化合物. 增值税率:17.0%. 退税率:13.0%. 监管条件:无. 最惠国关税:6.5%. 普通关税:20.0% |
| 申报要素 | 品名, 成分含量, 用途, 乌洛托品请注明外观, 6-己内酰胺请注明外观, 签约日期 |
| Summary | 2933599090. other compounds containing a pyrimidine ring (whether or not hydrogenated) or piperazine ring in the structure. VAT:17.0%. Tax rebate rate:13.0%. . MFN tariff:6.5%. General tariff:20.0% |